labor progressr. cases with minimal or no assistance, with or without episiotomy delivery in a completely normal case
Conditions
Interventions
Intervention 1: First group(54 person) receive atropin 0/01mg/kg max(0/5mg) single dose intramascular. Intervention 2: Second group (54 person) receive hyoscine 20mg single dose intramascular. Interve
Treatment - Drugs
First group(54 person) receive atropin 0/01mg/kg max(0/5mg) single dose intramascular
Second group (54 person) receive hyoscine 20mg single dose intramascular
Third group (54 person) receive distilled water 20mg single dose intramascular
Forth group(54 person) receive atropin 0/01mg/kg max0/5mg plus hyoscine 20mg single dose intramascular
Sponsors
Arak University of Medival Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: primigravida; cephalic presentation; age of pregnancy 37-42 weeks; dilatation of cervix 3-4 cm; membrane rupture and clear; no use cardiovascular drags; no use analgesic. Exclusion criteria: meconium amniotic fluid; drug reaction or sensitivity; cephalopelvic dicperoportion; macrosomiya.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Labor progress. Timepoint: before intervation and one hour after intervation. Method of measurement: vajinal exam. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: before intervention and one hour ater intervention. Method of measurement: vajnal exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehri Jamilian
Arak University of Medical Sciences
Outcome results
None listed